Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
JAMA
    July 2021
  1. SLOMSKI A
    Fewer Cardiovascular Events With Intensive Blood Pressure Control.
    JAMA. 2021;326:299.
    >> Share

  2. WILKINS JT, Lloyd-Jones DM
    Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
    JAMA. 2021;326:266-267.
    >> Share

  3. MIKSENAS H, Januzzi JL Jr, Natarajan P
    Lipoprotein(a) and Cardiovascular Diseases.
    JAMA. 2021 Jul 8. pii: 2781946. doi: 10.1001/jama.2021.3632.
    >> Share

    June 2021
  4. SATO T, Terada R, Ikeda T
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia.
    JAMA. 2021;325:2505-2506.
    >> Share

  5. DUCROCQ G, Simon T, Steg PG
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-Reply.
    JAMA. 2021;325:2506-2507.
    >> Share

  6. SOLOMON MD, Nguyen-Huynh M, Leong TK, Alexander J, et al
    Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges.
    JAMA. 2021 Jun 2. pii: 2780794. doi: 10.1001/jama.2021.8414.
    >> Share

    May 2021
  7. GOTTESMAN RF, Johansen MC
    Coronary Revascularization and Cognitive Decline: The Patient or the Procedure?
    JAMA. 2021;325:1941-1942.
    >> Share

  8. OGATA H, Fukagawa M, Hirakata H, Kagimura T, et al
    Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
    JAMA. 2021;325:1946-1954.
    >> Share

  9. WHITLOCK EL, Diaz-Ramirez LG, Smith AK, Boscardin WJ, et al
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults Undergoing Coronary Revascularization.
    JAMA. 2021;325:1955-1964.
    >> Share

  10. JOSHI PH, de Lemos JA
    Diagnosis and Management of Stable Angina: A Review.
    JAMA. 2021;325:1765-1778.
    >> Share

    April 2021
  11. EL-BATTRAWY I, Behnes M, Akin I
    Depression and Incident Cardiovascular Disease.
    JAMA. 2021;325:1679-1680.
    >> Share

  12. DAVIDSON KW, Pennells L, Di Angelantonio E
    Depression and Incident Cardiovascular Disease-Reply.
    JAMA. 2021;325:1680.
    >> Share

  13. ANCHAN R, Cifu AS, Paul J
    Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation.
    JAMA. 2021;325:1556-1557.
    >> Share

  14. RIGATELLI G, Zuin M
    Fractional Flow Reserve Treatment and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.
    JAMA. 2021;325:1565.
    >> Share

  15. SUD M, Fang J, Ko DT
    Fractional Flow Reserve Treatment and Major Adverse Cardiac Events in Patients With Coronary Artery Disease-Reply.
    JAMA. 2021;325:1565-1566.
    >> Share

  16. KAMRAN H, Jneid H, Kayani WT, Virani SS, et al
    Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.
    JAMA. 2021;325:1545-1555.
    >> Share

  17. WANG Y
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1333.
    >> Share

  18. OLSHANSKY B, Bhatt DL, Chung MK
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1332-1333.
    >> Share

  19. PARK KY, Park HK, Hwang HS
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1334.
    >> Share

  20. WELTY F, Bistrian B, Driscoll D
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1333.
    >> Share

  21. NISSEN SE, Lincoff AM, Nicholls SJ
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk-Reply.
    JAMA. 2021;325:1334-1335.
    >> Share

    March 2021
  22. SLOMSKI A
    Polypill Plus Aspirin Effective for Cardiovascular Disease Prevention.
    JAMA. 2021;325:1135.
    >> Share

  23. FRIEDEN TR, Foti KE
    National Initiatives to Prevent Myocardial Infarction and Stroke.
    JAMA. 2021 Mar 12. pii: 2777651. doi: 10.1001/jama.2021.0905.
    >> Share

  24. YOU SC, Gupta A, Krumholz HM
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention-Reply.
    JAMA. 2021;325:890-891.
    >> Share

  25. KIM HK, Kubica J, Jeong YH
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention.
    JAMA. 2021;325:890.
    >> Share

    February 2021
  26. KOLTE D, Libby P, Jang IK
    New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes.
    JAMA. 2021 Feb 22. pii: 2776938. doi: 10.1001/jama.2021.0069.
    >> Share

  27. PERAK AM, Lancki N, Kuang A, Labarthe DR, et al
    Associations of Maternal Cardiovascular Health in Pregnancy With Offspring Cardiovascular Health in Early Adolescence.
    JAMA. 2021;325:658-668.
    >> Share

  28. DANIELS SR
    Maternal Cardiovascular Health: A Critical Period for Offspring Lifetime Cardiovascular Health?
    JAMA. 2021;325:630-631.
    >> Share

  29. DUCROCQ G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, et al
    Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
    JAMA. 2021;325:552-560.
    >> Share

  30. KHATANA SAM, Venkataramani AS, Nathan AS, Dayoub EJ, et al
    Association Between County-Level Change in Economic Prosperity and Change in Cardiovascular Mortality Among Middle-aged US Adults.
    JAMA. 2021;325:445-453.
    >> Share

  31. WEEKS WB, Weinstein JN
    Economic Prosperity and Cardiovascular Mortality: Further Evidence That All Policy Is Health Policy.
    JAMA. 2021;325:439-440.
    >> Share

    January 2021
  32. LOPES RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, et al
    Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
    JAMA. 2021;325:254-264.
    >> Share

    December 2020
  33. SLOMSKI A
    Empagliflozin Cuts Cardiovascular Deaths in Advanced Heart Failure.
    JAMA. 2020;324:2476.
    >> Share

  34. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
    Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    JAMA. 2020;324:2396-2405.
    >> Share

  35. PATEL MM, Uyeki TM
    Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
    JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
    >> Share

  36. VARDENY O, Kim K, Udell JA, Joseph J, et al
    Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
    >> Share

    November 2020
  37. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2020;324:2069-2075.
    >> Share

  38. O'CONNOR EA, Evans CV, Rushkin MC, Redmond N, et al
    Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2020;324:2076-2094.
    >> Share

  39. JIN J
    Counseling on Healthy Diet and Physical Activity to Prevent Cardiovascular Disease.
    JAMA. 2020;324:2114.
    >> Share

  40. SMILOWITZ NR, Berger JS
    Cardiovascular Risk Assessment for Noncardiac Surgery-Reply.
    JAMA. 2020;324:2106-2107.
    >> Share

  41. GRASSHOFF C, Magunia H
    Cardiovascular Risk Assessment for Noncardiac Surgery.
    JAMA. 2020;324:2105-2106.
    >> Share

  42. KHAN SS, Greenland P
    Comprehensive Cardiovascular Health Promotion for Successful Prevention of Cardiovascular Disease.
    JAMA. 2020;324:2036-2037.
    >> Share

  43. SHARMA G, Martin SS, Blumenthal RS
    Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events: What Matters Most: the Drug, the Dose, or the Placebo?
    JAMA. 2020 Nov 15. pii: 2773118. doi: 10.1001/jama.2020.22387.
    >> Share

  44. NICHOLLS SJ, Lincoff AM, Garcia M, Bash D, et al
    Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
    JAMA. 2020 Nov 15. pii: 2773120. doi: 10.1001/jama.2020.22258.
    >> Share

  45. SUD M, Han L, Koh M, Austin PC, et al
    Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.
    JAMA. 2020 Nov 13. pii: 2773127. doi: 10.1001/jama.2020.22708.
    >> Share

  46. BACH RG
    Physiology-Based Revascularization Decisions and Improved Clinical Outcomes Following Percutaneous Coronary Interventions.
    JAMA. 2020 Nov 13. pii: 2773126. doi: 10.1001/jama.2020.22998.
    >> Share

    October 2020
  47. SLOMSKI A
    Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease.
    JAMA. 2020;324:1599.
    >> Share

  48. BATES ER
    Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes.
    JAMA. 2020;324:1613-1615.
    >> Share

  49. YOU SC, Rho Y, Bikdeli B, Kim J, et al
    Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    JAMA. 2020;324:1640-1650.
    >> Share

    August 2020
  50. PEREIRA NL, Farkouh ME, So D, Lennon R, et al
    Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
    JAMA. 2020;324:761-771.
    >> Share

  51. MOLITERNO DJ, Smyth SS, Abdel-Latif A
    CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions: One Size Rarely Fits All.
    JAMA. 2020;324:747-749.
    >> Share

    July 2020
  52. JABBAR A, Ingoe L, Junejo S, Carey P, et al
    Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial.
    JAMA. 2020;324:249-258.
    >> Share

  53. DHRUVA SS, Mortazavi BJ, Desai NR
    Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump for Cardiogenic Shock-Reply.
    JAMA. 2020;324:303-304.
    >> Share

  54. RAVN HB, Helgestad OKL, Moller JE
    Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump for Cardiogenic Shock.
    JAMA. 2020;324:302-303.
    >> Share

  55. RIZZO JA, Dove H
    Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump for Cardiogenic Shock.
    JAMA. 2020;324:303.
    >> Share

  56. SMILOWITZ NR, Berger JS
    Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review.
    JAMA. 2020;324:279-290.
    >> Share

  57. NISSEN SE, Bakaeen FG
    Coronary Revascularization Strategies: Making Sense of Sparse, Limited-Quality Data.
    JAMA. 2020;324:154-156.
    >> Share

  58. GAUDINO M, Benedetto U, Fremes S, Ballman K, et al
    Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis.
    JAMA. 2020;324:179-187.
    >> Share

  59. ORKABY AR, Driver JA, Ho YL, Lu B, et al
    Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    JAMA. 2020;324:68-78.
    >> Share

    June 2020
  60. HADAYA J, Benharash P
    Extracorporeal Membrane Oxygenation.
    JAMA. 2020;323:2536.
    >> Share

  61. KIM BK, Hong SJ, Cho YH, Yun KH, et al
    Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
    JAMA. 2020;323:2407-2416.
    >> Share

  62. KURTH T, Rist PM, Ridker PM, Kotler G, et al
    Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women.
    JAMA. 2020;323:2281-2289.
    >> Share

    May 2020
  63. HIRSCH IB, Gaudiani LM
    Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.
    JAMA. 2020 May 22. pii: 2766597. doi: 10.1001/jama.2020.1303.
    >> Share

  64. CROSS SH, Mehra MR, Bhatt DL, Nasir K, et al
    Rural-Urban Differences in Cardiovascular Mortality in the US, 1999-2017.
    JAMA. 2020;323:1852-1854.
    >> Share

    April 2020
  65. HONIGBERG MC, Natarajan P
    Premature Menopause and Risk for Cardiovascular Disease-Reply.
    JAMA. 2020;323:1617-1618.
    >> Share

  66. SCARABIN PY
    Premature Menopause and Risk for Cardiovascular Disease.
    JAMA. 2020;323:1616.
    >> Share

  67. ZHOU X, Tang G
    Premature Menopause and Risk for Cardiovascular Disease.
    JAMA. 2020;323:1616-1617.
    >> Share

  68. HAMPTON T
    After Heart Attack, Growth Factor Improves Scar Quality and Heart Function in Pig Study.
    JAMA. 2020;323:1235.
    >> Share

    March 2020
  69. PETRIE MC, Verma S, Docherty KF, Inzucchi SE, et al
    Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
    JAMA. 2020 Mar 27. pii: 2763950. doi: 10.1001/jama.2020.1906.
    >> Share

  70. PLUTZKY J
    Epigenetic Therapeutics for Cardiovascular Disease: Writing, Erasing, Reading, and Maybe Forgetting.
    JAMA. 2020 Mar 27. pii: 2763949. doi: 10.1001/jama.2020.3298.
    >> Share

  71. RAY KK, Nicholls SJ, Buhr KA, Ginsberg HN, et al
    Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2020 Mar 27. pii: 2763951. doi: 10.1001/jama.2020.3308.
    >> Share

  72. ABBASI J
    Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
    JAMA. 2020 Mar 18. pii: 2763421. doi: 10.1001/jama.2019.20983.
    >> Share

    February 2020
  73. LOPES RD, de Barros E Silva PGM, Damiani LP, Santos RHN, et al
    Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.
    JAMA. 2020;323:787-789.
    >> Share

  74. THIELE H, Desch S, Freund A
    Microaxial Left Ventricular Assist Devices: In Search of an Appropriate Indication.
    JAMA. 2020;323:716-718.
    >> Share

  75. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.
    JAMA. 2020 Feb 20. pii: 2761799. doi: 10.1001/jama.2020.1511.
    >> Share

  76. MOSLEY JD, Gupta DK, Tan J, Yao J, et al
    Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease.
    JAMA. 2020;323:627-635.
    >> Share

  77. PETERS AT, Mutharasan RK
    Aspirin for Prevention of Cardiovascular Disease.
    JAMA. 2020;323:676.
    >> Share

  78. ELLIOTT J, Bodinier B, Bond TA, Chadeau-Hyam M, et al
    Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.
    JAMA. 2020;323:636-645.
    >> Share

  79. KHAN SS, Cooper R, Greenland P
    Do Polygenic Risk Scores Improve Patient Selection for Prevention of Coronary Artery Disease?
    JAMA. 2020;323:614-615.
    >> Share

  80. DHRUVA SS, Ross JS, Mortazavi BJ, Hurley NC, et al
    Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    JAMA. 2020 Feb 10. pii: 2761003. doi: 10.1001/jama.2020.0254.
    >> Share

    January 2020
  81. MCEVOY JW, Daya N, Rahman F, Hoogeveen RC, et al
    Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes.
    JAMA. 2020;323:329-338.
    >> Share

    December 2019
  82. YANG WY, Zhang ZY, Staessen JA
    Blood Pressure Indexes Associated With Mortality and Cardiovascular Outcomes-Reply.
    JAMA. 2019;322:2343-2344.
    >> Share

  83. HUANG Y, Kuang J, Mai W
    Blood Pressure Indexes Associated With Mortality and Cardiovascular Outcomes.
    JAMA. 2019;322:2342-2343.
    >> Share

    November 2019
  84. SLOMSKI A
    Polypill More Effective Than Usual Care for Reducing Cardiovascular Risks.
    JAMA. 2019;322:1948.
    >> Share

  85. HUFFMAN MD, Salam A, Patel A
    Implementation Strategies for Cardiovascular Polypills.
    JAMA. 2019 Nov 25. pii: 2756238. doi: 10.1001/jama.2019.18102.
    >> Share

  86. JOYNER MJ, Paneth N
    Cardiovascular Disease Prevention at a Crossroads:: Precision Medicine or Polypill?
    JAMA. 2019 Nov 25. pii: 2756239. doi: 10.1001/jama.2019.19026.
    >> Share

  87. BAIREY MERZ CN
    Testing for Coronary Microvascular Dysfunction.
    JAMA. 2019 Nov 18. pii: 2755842. doi: 10.1001/jama.2019.16625.
    >> Share

  88. WEI J, Cheng S, Merz CNB
    Coronary Microvascular Dysfunction Causing Cardiac Ischemia in Women.
    JAMA. 2019 Nov 18. pii: 2755840. doi: 10.1001/jama.2019.15736.
    >> Share

  89. HONIGBERG MC, Zekavat SM, Aragam K, Finneran P, et al
    Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease.
    JAMA. 2019 Nov 18. pii: 2755841. doi: 10.1001/jama.2019.19191.
    >> Share

  90. GOLDBERG AC, Leiter LA, Stroes ESG, Baum SJ, et al
    Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
    JAMA. 2019;322:1780-1788.
    >> Share

  91. MEIJERS WC, Moslehi JJ
    Need for Multidisciplinary Research and Data-Driven Guidelines for the Cardiovascular Care of Patients With Cancer.
    JAMA. 2019;322:1775-1776.
    >> Share

  92. WATANABE H, Kimura T
    1 vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention-Reply.
    JAMA. 2019;322:1715-1716.
    >> Share

  93. TAN WK
    One vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention.
    JAMA. 2019;322:1715.
    >> Share

    October 2019
  94. HAHN JY, Song YB, Gwon HC
    P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention-Reply.
    JAMA. 2019;322:1607-1608.
    >> Share

  95. MCCAW ZR, Wei LJ
    P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.
    JAMA. 2019;322:1607.
    >> Share

  96. MORRIS NB, Gruss F, Lempert S, English T, et al
    A Preliminary Study of the Effect of Dousing and Foot Immersion on Cardiovascular and Thermal Responses to Extreme Heat.
    JAMA. 2019;322:1411-1413.
    >> Share

  97. JAIN A, Davis AM
    Primary Prevention of Cardiovascular Disease.
    JAMA. 2019 Oct 4:1-3. doi: 10.1001/jama.2019.15915.
    >> Share

    September 2019
  98. WEXLER DJ
    Sulfonylureas and Cardiovascular Safety: The Final Verdict?
    JAMA. 2019 Sep 19. pii: 2751396. doi: 10.1001/jama.2019.14533.
    >> Share

  99. ROUMIE CL, Chipman J, Min JY, Hackstadt AJ, et al
    Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function.
    JAMA. 2019 Sep 19:1-11. doi: 10.1001/jama.2019.13206.
    >> Share

  100. ROSENSTOCK J, Kahn SE, Johansen OE, Zinman B, et al
    Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
    JAMA. 2019 Sep 19. pii: 2751398. doi: 10.1001/jama.2019.13772.
    >> Share

  101. ABBASI J
    Cardiovascular Corner: Prescription Omega-3s, Stroke Rehab, and Statins After Age 75.
    JAMA. 2019 Sep 11. pii: 2751407. doi: 10.1001/jama.2019.14485.
    >> Share

  102. FERENCE BA, Bhatt DL, Catapano AL, Packard CJ, et al
    Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.
    JAMA. 2019 Sep 2. pii: 2749533. doi: 10.1001/jama.2019.14120.
    >> Share

  103. AMINIAN A, Zajichek A, Arterburn DE, Wolski KE, et al
    Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity.
    JAMA. 2019 Sep 2. pii: 2749478. doi: 10.1001/jama.2019.14231.
    >> Share

    August 2019
  104. DUNCAN MS, Freiberg MS, Greevy RA Jr, Kundu S, et al
    Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease.
    JAMA. 2019;322:642-650.
    >> Share

  105. COLE TB
    Smoking Cessation and Reduction of Cardiovascular Disease Risk.
    JAMA. 2019;322:651.
    >> Share

  106. YANG WY, Melgarejo JD, Thijs L, Zhang ZY, et al
    Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes.
    JAMA. 2019;322:409-420.
    >> Share

  107. ZHONG VW, Van Horn L, Allen NB
    Dietary Cholesterol or Egg Consumption and Cardiovascular Outcomes-Reply.
    JAMA. 2019;322:467.
    >> Share

  108. KEYSERLING TC, Berkowitz SA, Samuel-Hodge CD
    Dietary Cholesterol or Egg Consumption and Cardiovascular Outcomes.
    JAMA. 2019;322:466-467.
    >> Share

    July 2019
  109. JAHAN R, Saver JL, Schwamm LH, Fonarow GC, et al
    Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.
    JAMA. 2019;322:252-263.
    >> Share

    June 2019
  110. HAHN JY, Song YB, Oh JH, Chun WJ, et al
    Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
    JAMA. 2019;321:2428-2437.
    >> Share

  111. WATANABE H, Domei T, Morimoto T, Natsuaki M, et al
    Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
    JAMA. 2019;321:2414-2427.
    >> Share

  112. ABBASI J
    Cardiovascular Corner: Low Lipids, Metformin, and Plant-Based Diets.
    JAMA. 2019 Jun 12. pii: 2736162. doi: 10.1001/jama.2019.6544.
    >> Share

  113. ZHENG SL, Roddick AJ
    Meta-analysis of Aspirin for Primary Prevention of Cardiovascular Events-Reply.
    JAMA. 2019;321:2244-2245.
    >> Share

  114. SHAH R
    Meta-analysis of Aspirin for Primary Prevention of Cardiovascular Events.
    JAMA. 2019;321:2244.
    >> Share

  115. SYN NL, Wee IJY
    Meta-analysis of Aspirin for Primary Prevention of Cardiovascular Events.
    JAMA. 2019;321:2243-2244.
    >> Share

    May 2019
  116. BERRY C, McCartney PJ, Maznyczka AM
    Fibrinolytic Therapy to Reduce Microvascular Obstruction After Myocardial Infarction-Reply.
    JAMA. 2019;321:2033-2034.
    >> Share

  117. ALKHALIL M
    Fibrinolytic Therapy to Reduce Microvascular Obstruction After Myocardial Infarction.
    JAMA. 2019;321:2032-2033.
    >> Share

  118. SEZER M, Umman S
    Fibrinolytic Therapy to Reduce Microvascular Obstruction After Myocardial Infarction.
    JAMA. 2019;321:2032.
    >> Share

  119. CHAN MTV, Wang CY, Seet E, Tam S, et al
    Association of Unrecognized Obstructive Sleep Apnea With Postoperative Cardiovascular Events in Patients Undergoing Major Noncardiac Surgery.
    JAMA. 2019;321:1788-1798.
    >> Share

  120. AUCKLEY D, Memtsoudis S
    Unrecognized Obstructive Sleep Apnea and Postoperative Cardiovascular Complications: A Wake-up Call.
    JAMA. 2019;321:1774-1776.
    >> Share

  121. WISE RA, Chapman KR, Scirica BM, Bhatt DL, et al
    Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.
    JAMA. 2019;321:1693-1701.
    >> Share


  122. Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes.
    JAMA. 2019;321:1720-1721.
    >> Share

    April 2019
  123. GREGG EW, Hora I, Benoit SR
    Resurgence in Diabetes-Related Complications.
    JAMA. 2019 Apr 15. pii: 2730953. doi: 10.1001/jama.2019.3471.
    >> Share

  124. YANO Y, Muntner P, Lloyd-Jones D
    Hypertension in Young Adults and Subsequent Cardiovascular Disease-Reply.
    JAMA. 2019;321:1310-1311.
    >> Share

  125. DE KOUCHKOVSKY I, Mayfield J, Kohlwes J
    Hypertension in Young Adults and Subsequent Cardiovascular Disease.
    JAMA. 2019;321:1310.
    >> Share

    March 2019
  126. ZHONG VW, Van Horn L, Cornelis MC, Wilkins JT, et al
    Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality.
    JAMA. 2019;321:1081-1095.
    >> Share

  127. BONOW RO, Braunwald E
    The Evidence Supporting Cardiovascular Guidelines: Is There Evidence of Progress in the Last Decade?
    JAMA. 2019;321:1053-1054.
    >> Share

  128. ECKEL RH
    Reconsidering the Importance of the Association of Egg Consumption and Dietary Cholesterol With Cardiovascular Disease Risk.
    JAMA. 2019;321:1055-1056.
    >> Share

    February 2019
  129. HANEUSE S, VanderWeele TJ, Arterburn D
    Using the E-Value to Assess the Potential Effect of Unmeasured Confounding in Observational Studies.
    JAMA. 2019;321:602-603.
    >> Share

    January 2019
  130. FERENCE BA, Kastelein JJP, Ray KK, Ginsberg HN, et al
    Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    JAMA. 2019;321:364-373.
    >> Share

  131. NAVAR AM
    The Evolving Story of Triglycerides and Coronary Heart Disease Risk.
    JAMA. 2019;321:347-349.
    >> Share

  132. ZHENG SL, Roddick AJ
    Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.
    JAMA. 2019;321:277-287.
    >> Share

  133. MCCARTNEY PJ, Eteiba H, Maznyczka AM, McEntegart M, et al
    Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.
    JAMA. 2019;321:56-68.
    >> Share

  134. WANG TY, Kaltenbach LA, Cannon CP, Fonarow GC, et al
    Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial.
    JAMA. 2019;321:44-55.
    >> Share

  135. JACKEVICIUS CA, Ko DT
    Medication Co-payment Vouchers, Adherence With Antiplatelet Therapy, and Adverse Cardiovascular Events After Myocardial Infarction.
    JAMA. 2019;321:37-39.
    >> Share

    December 2018
  136. LOTTA LA, Wittemans LBL, Zuber V, Stewart ID, et al
    Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
    JAMA. 2018;320:2553-2563.
    >> Share

  137. WADHERA RK, Joynt Maddox KE, Wasfy JH, Haneuse S, et al
    Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia.
    JAMA. 2018;320:2542-2552.
    >> Share

  138. FONAROW GC
    Unintended Harm Associated With the Hospital Readmissions Reduction Program.
    JAMA. 2018;320:2539-2541.
    >> Share

  139. SAMIERI C, Empana JP
    Cardiovascular Health and Cognitive Decline-Reply.
    JAMA. 2018;320:2483-2484.
    >> Share

  140. HOWLAND RH
    Cardiovascular Health and Cognitive Decline.
    JAMA. 2018;320:2483.
    >> Share

    November 2018
  141. KIM JM, Stewart R, Yoon JS
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome-Reply.
    JAMA. 2018;320:2152-2153.
    >> Share

  142. RUST G
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome.
    JAMA. 2018;320:2152.
    >> Share

  143. ZIMMERMANN FM, El Farissi M, Tonino PAL
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome.
    JAMA. 2018;320:2151-2152.
    >> Share

  144. THOMBS BD, Ziegelstein RC
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome.
    JAMA. 2018;320:2151.
    >> Share

  145. ROSENSTOCK J, Perkovic V, Johansen OE, Cooper ME, et al
    Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
    JAMA. 2018 Nov 9. pii: 2714646. doi: 10.1001/jama.2018.18269.
    >> Share

  146. VAN SLOTEN TT, Tafflet M, Perier MC, Dugravot A, et al
    Association of Change in Cardiovascular Risk Factors With Incident Cardiovascular Events.
    JAMA. 2018;320:1793-1804.
    >> Share

  147. SON JS, Choi S, Kim K, Kim SM, et al
    Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
    JAMA. 2018;320:1783-1792.
    >> Share

  148. YANO Y, Reis JP, Colangelo LA, Shimbo D, et al
    Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.
    JAMA. 2018;320:1774-1782.
    >> Share

  149. VASAN RS
    High Blood Pressure in Young Adulthood and Risk of Premature Cardiovascular Disease: Calibrating Treatment Benefits to Potential Harm.
    JAMA. 2018;320:1760-1763.
    >> Share

    October 2018
  150. SLOMSKI A
    No Cardiovascular Protection From Omega-3 Fatty Acids.
    JAMA. 2018;320:1631.
    >> Share

  151. ABBASI J
    To Prevent Cardiovascular Disease, Pay Attention to Pregnancy Complications.
    JAMA. 2018 Oct 17. pii: 2708197. doi: 10.1001/jama.2018.14645.
    >> Share

  152. VOELKER R
    Device Approved to Seal Coronary Artery Perforations.
    JAMA. 2018;320:1528.
    >> Share

  153. FISHER DP, Johnson E, Haneuse S, Arterburn D, et al
    Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
    JAMA. 2018;320:1570-1582.
    >> Share

  154. ABBASI J
    Researchers Test New Techniques to Rule Out and Predict Heart Attacks.
    JAMA. 2018;320:1425.
    >> Share

    September 2018
  155. BHATT DL
    Fractional Flow Reserve Measurement for the Physiological Assessment of Coronary Artery Stenosis Severity.
    JAMA. 2018;320:1275-1276.
    >> Share

  156. FRIEDRICH MJ
    Cardiovascular Disease in India.
    JAMA. 2018;320:1097.
    >> Share

  157. ZHU Y, Zhao Q
    Antiplatelet Therapy After Coronary Artery Bypass Grafting-Reply.
    JAMA. 2018;320:1036-1037.
    >> Share

  158. SHAH R, Hesterberg K
    Antiplatelet Therapy After Coronary Artery Bypass Grafting.
    JAMA. 2018;320:1035.
    >> Share

  159. MORI M, Geirsson A
    Antiplatelet Therapy After Coronary Artery Bypass Grafting.
    JAMA. 2018;320:1035-1036.
    >> Share

  160. WRIGHT JS, Wall HK, Ritchey MD
    Million Hearts 2022: Small Steps Are Needed for Cardiovascular Disease Prevention.
    JAMA. 2018 Sep 6. pii: 2702070. doi: 10.1001/jama.2018.13326.
    >> Share

    August 2018
  161. WILLIAMSON W, Lewandowski AJ, Forkert ND, Griffanti L, et al
    Association of Cardiovascular Risk Factors With MRI Indices of Cerebrovascular Structure and Function and White Matter Hyperintensities in Young Adults.
    JAMA. 2018;320:665-673.
    >> Share

  162. SAMIERI C, Perier MC, Gaye B, Proust-Lima C, et al
    Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia.
    JAMA. 2018;320:657-664.
    >> Share

  163. SAVER JL, Cushman M
    Striving for Ideal Cardiovascular and Brain Health: It Is Never Too Early or Too Late.
    JAMA. 2018;320:645-647.
    >> Share

    July 2018
  164. DONADINI MP, Bellesini M, Squizzato A
    Aspirin Plus Clopidogrel vs Aspirin Alone for Preventing Cardiovascular Events Among Patients at High Risk for Cardiovascular Events.
    JAMA. 2018 Jul 26. pii: 2695067. doi: 10.1001/jama.2018.9641.
    >> Share

  165. KIM JM, Stewart R, Lee YS, Lee HJ, et al
    Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.
    JAMA. 2018;320:350-358.
    >> Share

  166. RUBIN R
    Red Meat Allergy Associated With Coronary Artery Plaque.
    JAMA. 2018;320:331.
    >> Share

  167. JIN J
    Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors.
    JAMA. 2018;320:316.
    >> Share

  168. WILKINS JT, Lloyd-Jones DM
    USPSTF Recommendations for Assessment of Cardiovascular Risk With Nontraditional Risk Factors: Finding the Right Tests for the Right Patients.
    JAMA. 2018 Jul 10. pii: 2687223. doi: 10.1001/jama.2018.9346.
    >> Share

  169. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;320:177-183.
    >> Share

  170. LIN JS, Evans CV, Johnson E, Redmond N, et al
    Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018 Jul 10. pii: 2687224. doi: 10.1001/jama.2018.4242.
    >> Share

  171. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018 Jul 10. pii: 2687225. doi: 10.1001/jama.2018.8359.
    >> Share

    June 2018
  172. SELAK V, Kerr A, Poppe K, Wu B, et al
    Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy.
    JAMA. 2018;319:2507-2520.
    >> Share

  173. JONAS DE, Reddy S, Middleton JC, Barclay C, et al
    Screening for Cardiovascular Disease Risk With Resting or Exercise Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;319:2315-2328.
    >> Share

  174. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;319:2308-2314.
    >> Share

  175. JIN J
    Screening for Cardiovascular Disease Risk With ECG.
    JAMA. 2018;319:2346.
    >> Share

  176. MCCARTHY CP, Vaduganathan M, Januzzi JL Jr
    Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment.
    JAMA. 2018 Jun 11. pii: 2684931. doi: 10.1001/jama.2018.7125.
    >> Share

  177. MERCHANT FM, Dickert NW Jr, Howard DH
    Mandatory Shared Decision Making by the Centers for Medicare & Medicaid Services for Cardiovascular Procedures and Other Tests.
    JAMA. 2018 Jun 4. pii: 2683805. doi: 10.1001/jama.2018.6617.
    >> Share

    May 2018
  178. BHATT DL
    Percutaneous Coronary Intervention in 2018.
    JAMA. 2018;319:2127-2128.
    >> Share

  179. ABBASI J
    Another Nail in the Coffin for Fish Oil Supplements.
    JAMA. 2018;319:1851-1852.
    >> Share

    April 2018
  180. ZHAO Q, Zhu Y, Xu Z, Cheng Z, et al
    Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    JAMA. 2018;319:1677-1686.
    >> Share

  181. ALEXANDER JH
    Ticagrelor Following Coronary Artery Bypass Grafting: For Better Vein Graft Patency or Better Patient Outcomes?
    JAMA. 2018;319:1661-1662.
    >> Share

  182. NAVARESE EP, Robinson JG, Kowalewski M, Kolodziejczak M, et al
    Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.
    JAMA. 2018;319:1566-1579.
    >> Share

  183. ABBASI J
    Using Heart Pump Data to Manage Cardiogenic Shock.
    JAMA. 2018;319:1427.
    >> Share

  184. YU K, Qiu G, Chan KH, Lam KH, et al
    Association of Solid Fuel Use With Risk of Cardiovascular and All-Cause Mortality in Rural China.
    JAMA. 2018;319:1351-1361.
    >> Share

    March 2018
  185. GUPTA A, Das SR, Pandey A
    beta-Blockers in Myocardial Infarction: Issues With Standard Admission Order Sets.
    JAMA. 2018;319:1269-1270.
    >> Share

  186. BERWANGER O, Santucci EV, de Barros E Silva PGM, Jesuino IA, et al
    Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
    JAMA. 2018 Mar 11. pii: 2675023. doi: 10.1001/jama.2018.2444.
    >> Share

  187. NICHOLLS SJ, Psaltis PJ
    Lipid Lowering in Acute Coronary Syndrome: Is Treatment Early Enough?
    JAMA. 2018 Mar 11. pii: 2675022. doi: 10.1001/jama.2018.2426.
    >> Share

  188. ABBASI J
    Do All Patients Need beta-Blockers After a Heart Attack?
    JAMA. 2018;319:853-855.
    >> Share

    February 2018
  189. HUFFMAN MD, Mohanan PP, Devarajan R, Baldridge AS, et al
    Effect of a Quality Improvement Intervention on Clinical Outcomes in Patients in India With Acute Myocardial Infarction: The ACS QUIK Randomized Clinical Trial.
    JAMA. 2018;319:567-578.
    >> Share

    January 2018
  190. WADHERA RK, Yeh RW, Joynt Maddox KE
    The Rise and Fall of Mandatory Cardiac Bundled Payments.
    JAMA. 2018;319:335-336.
    >> Share

  191. KENNEDY AB, Lavie CJ, Blair SN
    Fitness or Fatness: Which Is More Important?
    JAMA. 2018;319:231-232.
    >> Share

    December 2017
  192. GREENLAND P
    Cardiovascular Guideline Skepticism vs Lifestyle Realism?
    JAMA. 2017 Dec 14. pii: 2666625. doi: 10.1001/jama.2017.19675.
    >> Share

    November 2017
  193. SLOMSKI A
    Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status.
    JAMA. 2017;318:1968.
    >> Share

  194. EMDIN CA, Khera AV, Kathiresan S
    Mendelian Randomization.
    JAMA. 2017;318:1925-1926.
    >> Share

  195. IRONY TZ
    The "Utility" in Composite Outcome Measures: Measuring What Is Important to Patients.
    JAMA. 2017;318:1820-1821.
    >> Share

  196. CHAPMAN AR, Lee KK, McAllister DA, Cullen L, et al
    Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome.
    JAMA. 2017 Nov 11. doi: 10.1001/jama.2017.17488.
    >> Share

    October 2017
  197. ABBASI J
    Could a New Method to Detect Coronary Inflammation Prevent Heart Attacks?
    JAMA. 2017;318:1527-1528.
    >> Share

    September 2017
  198. WADHERA RK, Bhatt DL
    Taking the "Public" Out of Public Reporting of Percutaneous Coronary Intervention.
    JAMA. 2017 Sep 28. doi: 10.1001/jama.2017.12087.
    >> Share

  199. LICHTMAN JH, Jones MR, Leifheit EC, Sheffet AJ, et al
    Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014.
    JAMA. 2017;318:1035-1046.
    >> Share

  200. BARNARD ND, Willett WC, Ding EL
    The Misuse of Meta-analysis in Nutrition Research.
    JAMA. 2017 Sep 18. doi: 10.1001/jama.2017.12083.
    >> Share

  201. DEVEREAUX PJ, Biccard BM, Chan MTV
    High-Sensitivity Troponin Levels, Ischemia, and Mortality-Reply.
    JAMA. 2017;318:865.
    >> Share

  202. SMILOWITZ NR
    High-Sensitivity Troponin Levels, Ischemia, and Mortality.
    JAMA. 2017;318:864-865.
    >> Share

    August 2017
  203. KRUMHOLZ HM
    Treatment of Cholesterol in 2017.
    JAMA. 2017;318:417-418.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016